First Patient Treated with Civacir® after Hepatitis C Induced Liver ... PR Newswire (press release) After treatment with virostatics over several weeks, the first patient underwent liver transplantation and subsequently was treated with the Civacir in the Phase III clinical trial. Civacir, a 10 % hepatitis C hyperimmune globulin developed and ... Biotest commences phase III trial of hepatitis C therapy |
